郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

期刊：British journal of pharmacology发表年份：2011作者：R J Slack; L J Russell; D A Hall; M A Luttmann; A J Ford; K A Saunders; S T Hodgson; H E Connor; C Browning; K L Clark
阅读更多 →

药效评价The DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) Are stimulated by bulky adduct-containing DNA.

期刊：The Journal of biological chemistry发表年份：2011作者：Michael G Kemp; Laura A Lindsey-Boltz; Aziz Sancar
阅读更多 →

药效评价In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.

期刊：British journal of pharmacology发表年份：2011作者：K J af Forselles; J Root; T Clarke; D Davey; K Aughton; K Dack; N Pullen
阅读更多 →

药效评价Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels.

期刊：British journal of pharmacology发表年份：2011作者：Wen-Ning Wu; Peng-Fei Wu; Xiang-Long Chen; Zui Zhang; Jun Gu; Yuan-Jian Yang; Qiu-Ju Xiong; Lan Ni; Fang Wang; Jian-Guo Chen
阅读更多 →